Other languages Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			Pre-market 13:00:13
65.42 ^USD	+0.23%		64.56	-1.31%

04-26	TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90	MT
04-26	Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95	MT

Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy	04-26
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	04-26
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	04-26
EE.UU. - Valores a seguir en Wall Street	04-26
Gilead Sciences : dans le rouge au premier trimestre après ses acquisitions	04-26
Gilead Sciences, Inc. Announces U.S. Food and Drug Administration Approve Biktarvy® Label Update With Data for Pregnant Adults With HIV	04-26
En Direct des Marchés : TotalEnergies, Saint-Gobain, Safran, Airbus, Unibail, BHP, Microsoft, Alphabet...	04-26
Gilead abaisse ses prévisions pour 2024 après plusieurs charges exceptionnelles	04-25
Gilead Sciences Q1 Tops Estimates, Updates Outlook	04-25
Gilead Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25
Gilead posts quarterly loss, revenue rises 5%	04-25
Gilead Sciences, Inc. Revises Earnings Guidance for the Full Year 2024	04-25
Gilead Sciences, Inc. Declares a Dividend for the Second Quarter of 2024, Payable on June 27, 2024	04-25
WOCHENVORSCHAU: Termine bis 26. April 2024	04-12
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences	04-02
Sector Update: Health Care Stocks Slide Late Afternoon	04-01
Top Midday Gainers	04-01
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	04-01
Top Premarket Gainers	04-01
Gilead Sciences Files a Definitive Proxy Statement	03-28

No results for this search